In conclusion, the fasting glucagon concentrations are lowered in patients with VLCAD deficiency, and this is likely driven by the defect of FAO in itself rather than altered factors in the plasma. This evidence concerns the gene GCG and very long chain acyl-CoA dehydrogenase deficiency.